COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01305746
Recruitment Status : Completed
First Posted : March 1, 2011
Last Update Posted : February 13, 2014
Information provided by (Responsible Party):
Anthera Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2013
Actual Study Completion Date : October 2013